These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11241456)

  • 1. Differences in HCV antibody patterns in haemodialysis patients infected with the same virus isolate.
    de Oliveira JM; Rispeter K; Viazov S; Saback FL; Roggendorf M; Yoshida CF
    J Med Virol; 2001 Apr; 63(4):265-70. PubMed ID: 11241456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
    Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
    Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the full-length HCV core subgenome from HCV gentoype-1a and genotype-3a and evaluation of the antigenicity of translational products.
    Ansari MA; Irshad M; Agarwal SK; Chosdol K
    Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):806-13. PubMed ID: 23442416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the antibody reactivity to synthetic peptides from different parts of the hepatitis C virus genome.
    Pujol FH; Khudyakov YE; Devesa M; León G; Blitz-Dorfman L; Monsalve F; Lambert SB; Kalinina TY; Liprandi F; Fields HA
    Viral Immunol; 1996; 9(2):89-96. PubMed ID: 8822625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and clinical features of hepatitis C virus type 6 infections in blood donors from Hong Kong.
    Prescott LE; Simmonds P; Lai CL; Chan NK; Pike I; Yap PL; Lin CK
    J Med Virol; 1996 Oct; 50(2):168-75. PubMed ID: 8915883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic variation of core, NS3, and NS5 proteins among genotypes of hepatitis C virus.
    Neville JA; Prescott LE; Bhattacherjee V; Adams N; Pike I; Rodgers B; El-Zayadi A; Hamid S; Dusheiko GM; Saeed AA; Haydon GH; Simmonds P
    J Clin Microbiol; 1997 Dec; 35(12):3062-70. PubMed ID: 9399495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of interferon treatment on the antiviral T-cell response in hepatitis C virus genotype 1b- and genotype 2c-infected patients.
    Missale G; Cariani E; Lamonaca V; Ravaggi A; Rossini A; Bertoni R; Houghton M; Matsuura Y; Miyamura T; Fiaccadori F; Ferrari C
    Hepatology; 1997 Sep; 26(3):792-7. PubMed ID: 9303515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring antibody titers to recombinant Core-NS3 fusion polypeptide is useful for evaluating hepatitis C virus infection and responses to interferon-alpha therapy.
    Park YM; Byun BH; Choi JY; Bae SH; Kim BS; So HS; Ryu WS
    J Korean Med Sci; 1999 Apr; 14(2):165-70. PubMed ID: 10331562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of hepatitis C virus seroconversion resulting from nosocomial transmission on a haemodialysis unit: implications for infection control and laboratory screening.
    Irish DN; Blake C; Christophers J; Craske JE; Burnapp L; Abbs IC; MacMahon EM; Muir P; Banatvala JE; Simmonds P
    J Med Virol; 1999 Oct; 59(2):135-40. PubMed ID: 10459146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation between reactivity to the NS-4 region peptides of hepatitis C virus (HCV) and clinical features among patients infected with HCV genotype 1b.
    Sakugawa H; Nakasone H; Nakayoshi T; Kawakami Y; Kinjo F; Saito A; Nakayoshi T; Yamashiro A
    Microbiol Immunol; 1998; 42(4):299-303. PubMed ID: 9623917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative signal of anti-HCV by an automated assay predicts viremia in a population at high prevalence of hepatitis C virus infection.
    Bossi V; Galli C
    J Clin Virol; 2004 May; 30(1):45-9. PubMed ID: 15072753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of IgM anti-HCV core level in chronic hepatitis C.
    Papatheodoridis GV; Delladetsima JK; Katsoulidou A; Sypsa V; Albrecht M; Michel G; Hatzakis A; Tassopoulos NC
    J Hepatol; 1997 Jul; 27(1):36-41. PubMed ID: 9252071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a total core antigen assay for the diagnosis of hepatitis C virus infection in hemodialysis patients.
    Bouzgarrou N; Fodha I; Othman SB; Achour A; Grattard F; Trabelsi A; Pozzetto B
    J Med Virol; 2005 Dec; 77(4):502-8. PubMed ID: 16254976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus serotype-specific core and NS4 antibodies in injecting drug users participating in the Amsterdam cohort studies.
    Beld M; Penning M; van Putten M; van den Hoek A; Lukashov V; McMorrow M; Goudsmit J
    J Clin Microbiol; 1998 Oct; 36(10):3002-6. PubMed ID: 9738057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection.
    Lavillette D; Morice Y; Germanidis G; Donot P; Soulier A; Pagkalos E; Sakellariou G; Intrator L; Bartosch B; Pawlotsky JM; Cosset FL
    J Virol; 2005 May; 79(10):6023-34. PubMed ID: 15857988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Memory T-cell-mediated immune responses specific to an alternative core protein in hepatitis C virus infection.
    Bain C; Parroche P; Lavergne JP; Duverger B; Vieux C; Dubois V; Komurian-Pradel F; Trépo C; Gebuhrer L; Paranhos-Baccala G; Penin F; Inchauspé G
    J Virol; 2004 Oct; 78(19):10460-9. PubMed ID: 15367612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals.
    Valcavi P; Medici MC; Casula F; Arcangeletti MC; De Conto F; Pinardi F; Calderaro A; Chezzi C; Dettori G
    J Med Virol; 2004 Jul; 73(3):397-403. PubMed ID: 15170635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of anti-hepatitis C virus core IgM antibodies in patients with chronic hepatitis C.
    Pawlotsky JM; Darthuy F; Rémiré J; Pellet C; Udin L; Stuyver L; Roudot-Thoraval F; Duvoux C; Douvin C; Mallat A
    J Med Virol; 1995 Nov; 47(3):285-91. PubMed ID: 8551282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of variable regions of hepatitis C virus proteins: selection and modification of peptide epitopes to assess hepatitis C virus genotypes by ELISA.
    Rodr Guez-L Pez M; Riezu-Boj JI; Ruiz M; Berasain C; Civeira MP; Prieto J; Borr S-Cuesta F
    J Gen Virol; 1999 Mar; 80 ( Pt 3)():727-738. PubMed ID: 10092013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus infection in Jordanian haemodialysis units: serological diagnosis and genotyping.
    Bdour S
    J Med Microbiol; 2002 Aug; 51(8):700-704. PubMed ID: 12171303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.